Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer

1. Juanpere, N.
2. Agell, L.
3. Lorenzo, M.
4. De Muga, S.
5. López-Vilaró, L.
6. Murillo, R.
7. Mojal, S.
8. Serrano, S.
9. Lorente, J.A.
10. Lloreta, J.
11. Hernández, S.